Pain Following the Use of Anesthesia Formulation Among Individuals Undergoing Cataract Surgery: A Randomized Controlled Trial.
cataract surgery
intraocular anesthesia
lidocaine
ophthalmologic anesthesia
pain
phenylephrine
tropicamide
Journal
Frontiers in pharmacology
ISSN: 1663-9812
Titre abrégé: Front Pharmacol
Pays: Switzerland
ID NLM: 101548923
Informations de publication
Date de publication:
2020
2020
Historique:
received:
24
11
2019
accepted:
20
03
2020
entrez:
7
5
2020
pubmed:
7
5
2020
medline:
7
5
2020
Statut:
epublish
Résumé
To assess the pain intensity of two intracameral anesthetic solutions in patients undergoing cataract surgery and evaluate the factors influencing the patients' postoperative activities. Sixty-two patients undergoing cataract surgery were randomized to receive the study drug - a manufactured solution of 0.02% tropicamide/0.31% phenylephrine/1% lidocaine (Mydrane) or a traditional anesthetic formulation - solution of 1% lidocaine/0.025% adrenaline as an intraocular anesthetic. The pain intensity was assessed by Visual Analog Scale for Pain (VAS Pain) and Brief Pain Inventory-short form (BPI) on the next day after the surgery. The mean pain score measured preoperatively with VAS Pain was 0.34 in Mydrane group and 0.09 in the reference group ( New commercially available intraocular anesthetic solution (Mydrane™) seems to be as effective as off-label traditional anesthetic formulation, in reducing the pain experienced during cataract surgery under topical anesthesia.
Identifiants
pubmed: 32372954
doi: 10.3389/fphar.2020.00440
pmc: PMC7176993
doi:
Types de publication
Journal Article
Langues
eng
Pagination
440Informations de copyright
Copyright © 2020 Toro, Nowakowska, Brzozowska, Reibaldi, Avitabile, Bucolo, Murabito, Chisari, Nowomiejska and Rejdak.
Références
Br J Ophthalmol. 2016 Jul;100(7):976-985
pubmed: 26531052
Pain. 2015 Apr;156(4):609-17
pubmed: 25790453
J Cataract Refract Surg. 2017 May;43(5):597-605
pubmed: 28602319
Br J Ophthalmol. 2011 Jun;95(6):837-41
pubmed: 21183518
Surv Ophthalmol. 2015 May-Jun;60(3):196-203
pubmed: 25890623
Ophthalmology. 1999 Jan;106(1):60-6
pubmed: 9917782
Br J Ophthalmol. 2018 Jun;102(6):784-789
pubmed: 28903962
Gen Physiol Biophys. 2012 Jun;31(2):185-94
pubmed: 22781822
AAPS J. 2008 Jun;10(2):229-41
pubmed: 18437583
Retina. 2012 Apr;32(4):696-700
pubmed: 22082694
J Cataract Refract Surg. 1998 Jul;24(7):961-3
pubmed: 9682118
J Cataract Refract Surg. 2015 Oct;41(10):2035
pubmed: 26703275
BMC Ophthalmol. 2018 Apr 19;18(1):104
pubmed: 29673317
Cont Lens Anterior Eye. 2018 Oct;41(5):448-451
pubmed: 29807771
Clin Ophthalmol. 2013;7:1429-35
pubmed: 23885165
Nippon Ganka Gakkai Zasshi. 2012 Feb;116(2):86-94
pubmed: 22509696
J Cataract Refract Surg. 2015 Oct;41(10):2060-8
pubmed: 26703280
J Cataract Refract Surg. 2010 Jan;36(1):133-52
pubmed: 20117717
Ther Clin Risk Manag. 2016 Jan 22;12:93-102
pubmed: 26858525
Eur J Cardiovasc Nurs. 2016 Feb;15(1):47-54
pubmed: 25192967
Pain. 1976 Jun;2(2):175-84
pubmed: 1026900
Cutan Ocul Toxicol. 2010 Mar;29(1):41-9
pubmed: 20148736
Indian J Ophthalmol. 2013 Jul;61(7):319-24
pubmed: 23552356
J Cataract Refract Surg. 2015 Apr;41(4):719-23
pubmed: 25840296
Pain. 1979 Jun;6(3):247-8
pubmed: 460931
J Cataract Refract Surg. 2009 Feb;35(2):273-6
pubmed: 19185242
Curr Eye Res. 2013 Feb;38(2):278-82
pubmed: 23330822
J Cataract Refract Surg. 2013 May;39(5):789-98
pubmed: 23608571
Rehabil Psychol. 2015 Nov;60(4):365-6
pubmed: 26618216